Vaccines remain one of the most effective medical interventions, credited with saving over 150 million lives in the past five decades, as highlighted by European Commission President Ursula von der Leyen during her speech at the Gavi Replenishment Conference on June 25, 2025. The urgency of vaccine access and resilience was at the core of her address, wherein she outlined Europe's continued support and new initiatives to empower local production, especially across Africa.
Concrete Financial Commitments and Partnership Calls President von der Leyen announced a €360 million pledge to Gavi, part of Team Europe's larger commitment which totals €2 billion or more. This financial backing underlines the EU’s role as Gavi’s largest donor and reflects a firm policy orientation towards maintaining strong EU involvement in global health through funding multilateral initiatives. Additionally, she invited other partners to match this ambition to prevent diseases turning into “preventable tragedies.”
Push for Local Manufacturing and Supply Chain Security Going beyond funding, von der Leyen emphasized a strategic shift to enhancing local vaccine production capacity, especially in Africa where 99% of vaccines remain imported. Citing investments over €2 billion in various African countries, she pointed to ongoing projects and new mechanisms like a volume guarantee worth over €100 million, developed with the European Investment Bank and the Gates Foundation, to stabilize demand and incentivize vaccine manufacturing within developing markets.
Policy Cleavages and Stakeholder Implications This speech reflects an inclination toward increasing EU’s role beyond mere donor to a partner fostering local industry, thus raising EU integration in global health matters while promoting African regional autonomy in vaccine production. While national authorities in African countries stand to gain increased infrastructure and economic development, local manufacturers face growth opportunities balanced by expectations for reliability and scale. EU taxpayers see a defined budgetary outlay aligned with global health diplomacy goals, and global health NGOs are positioned to leverage stronger partnerships but may request impact assessments to ensure developments meet equitable access standards.
President von der Leyen’s address combines measured financial commitments with structural initiatives to build resilience, signaling an EU policy landscape that favors global collaboration, regional empowerment, and strategic investments over vague commitments, potentially reshaping vaccine access and production dynamics worldwide.
← Atlas › News › Development & Humanitarian Aid